← Back to Bills
S. 3087Senate119th Congress (2025-2027)In Committee

Stop Pills That Kill Act

Sponsored by Chuck GrassleySen. Chuck Grassley (R-IA)
Introduced October 30, 2025

AI-Generated Summary

Updated November 23, 2025 at 7:59 PM UTC

The Stop Pills That Kill Act amends the Controlled Substances Act to make it illegal to produce, sell, or possess fentanyl, its analogues, or counterfeit fentanyl/methamphetamine pills. It defines what counts as a counterfeit pill, orders the DEA to develop a plan to combat these pills within six months, and requires yearly congressional reports on seizures, prosecutions, and prevention activities. The bill targets illicit manufacturers, distributors, and traffickers of counterfeit opioid and stimulant pills, as well as the agencies tasked with stopping them.

Key Provisions

  • Adds “fentanyl, an analogue of fentanyl, or a counterfeit substance” to the list of drugs whose manufacturing, distribution, or possession with intent to distribute is prohibited under the Controlled Substances Act.
  • Defines a “counterfeit fentanyl or methamphetamine substance” as any product that contains fentanyl, its analogues, or methamphetamine and is falsely marketed or bears a fake trademark or label.
  • Requires the DEA Administrator to create, within 180 days, a comprehensive operation and response plan targeting counterfeit fentanyl or methamphetamine pills, including law‑enforcement strategies, youth‑focused education and prevention, and an audit of existing campaigns such as “One Pill Can Kill.”
  • Mandates an annual report from the Attorney General (in consultation with the DEA and ONDCP) to Congress detailing seizures, pill‑form breakdowns, substances found, geographic data, charges, convictions, sentences, and prevention efforts related to counterfeit fentanyl or methamphetamine pills.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

1 earlier action
SenateIntro Referral Latest Action

Read twice and referred to the Committee on the Judiciary.

Judiciary Committee

October 30, 2025

View full timeline
SenateIntro Referral

Introduced in Senate

October 30, 2025

SenateIntro Referral

Read twice and referred to the Committee on the Judiciary.

Judiciary Committee

October 30, 2025

Bill Text

Latest available legislative text

Reading Mode
Latest
Raw Text PDF XML
Introduced in SenateIssued October 30, 2025

II

119th CONGRESS

1st Session

S. 3087

IN THE SENATE OF THE UNITED STATES

October 30, 2025

Mr. Grassley (for himself and Ms. Hassan) introduced the following bill; which was read twice and referred to the Committee on the Judiciary

A BILL

To amend the Controlled Substances Act to prohibit certain acts related to fentanyl, analogues of fentanyl, and counterfeit substances, and for other purposes.

1.

Short title

This Act may be cited as the Stop Pills That Kill Act.

2.

Definition

In this Act, the term counterfeit fentanyl or methamphetamine substance means a substance that—

(1)

contains fentanyl, any analogue of fentanyl, or methamphetamine; and

(2)

is marketed, sold, or falsely bears the trademark, trade name, or other identifying mark, imprint, number, or any likeness thereof of another product.

3.

Prohibited acts

Section 403(d)(2) of the Controlled Substances Act (21 U.S.C. 843(d)(2)) is amended, in the matter preceding subparagraph (A), by inserting , fentanyl, an analogue of fentanyl, or a counterfeit substance after methamphetamine.

4.

Comprehensive plan

Not later than 180 days after the date of enactment of this Act, the Administrator of the Drug Enforcement Administration shall establish and implement an operation and response plan to address counterfeit fentanyl or methamphetamine substances that includes—

(1)

strategies to enable and empower Federal law enforcement efforts to investigate and seize counterfeit fentanyl or methamphetamine substances;

(2)

specific ways that education and prevention efforts to stop the use of counterfeit fentanyl or methamphetamine substances will be increased, including how—

(A)

ongoing efforts, such as Operation Engage, are effective in increasing education and prevention; and

(B)

how the efforts described in subparagraph (A) are tailored to youth and teen access; and

(3)

an audit of current campaigns, including the One Pill Can Kill campaign, on counterfeit fentanyl or methamphetamine substances, including a review of data and other available information on how the campaigns can be tailored, adjusted, or improved to better address the flow of counterfeit fentanyl or methamphetamine substances.

5.

Report to Congress

(a)

Report

Not later than 1 year after the date of enactment of this Act, and every year thereafter, the Attorney General, in consultation with the Administrator of the Drug Enforcement Administration and Director of the Office of National Drug Control Policy, shall submit to Congress a report on information regarding the collection and prosecutions of counterfeit fentanyl or methamphetamine substances.

(b)

Contents

The report required under subsection (a) shall include the following:

(1)

Data on the aggregate number of counterfeit fentanyl or methamphetamine substances seized and collected by Federal law enforcement agencies.

(2)

A breakdown on how many counterfeit fentanyl or methamphetamine substances are in pill form.

(3)

A breakdown on which illicit substances are present in the counterfeit fentanyl or methamphetamine substances that are in pill form.

(4)

Data outlining where and when counterfeit fentanyl or methamphetamine substances were seized.

(5)

Data on the charges filed against those manufacturing, distributing or dispensing, or possessing with the intent to distribute or dispense, a counterfeit fentanyl or methamphetamine substance, particularly in pill form, pursuant to paragraph (1) or (2) of section 401(a) of the Controlled Substances Act (21 U.S.C. 841(a)), unless disclosure of the data would—

(A)

require unsealing an indictment; or

(B)

undermine investigations and charges brought by the Department of Justice.

(6)

Data on the convictions and sentences against those who are found guilty under paragraph (1) or (2) of section 401(a) of the Controlled Substances Act (21 U.S.C. 841(a)) as it pertains to counterfeit fentanyl or methamphetamine substances, particularly those in pill form.

(7)

Any prevention measures that the Department of Justice, Drug Enforcement Administration, or Office of National Drug Control Policy are undertaking to limit and reduce the spread of counterfeit fentanyl or methamphetamine substances in pill form, including ongoing public awareness campaigns.